Gregg L. Semenza
Scientific Advisory Board – Professor at Johns Hopkins at Medical Excellence Capital
About
Leading molecular biologist and 2019 Nobel Prize winner for his discovery of the HIF-1 protein that controls gene expression in response to oxygen availability. He serves as professor at Johns Hopkins School of Medicine and directs the vascular program at the Institute for Cell Engineering.
Colleagues at Medical Excellence Capital
Annabel Stoddart
Office Manager and Executive Assistant at Medical Excellence Capital
Brad Ringeisen
Scientific Advisory Board – Executive Director of Innovative Genomics Institute at Medical Excellence Capital
Brian Halak
Managing Partner at Medical Excellence Capital
Douglas C Wallace
Scientific Advisory Board – Director of Center for Mitochondrial and Epigenomic Medicine at Medical Excellence Capital
Eric Heil
Managing Partner at Medical Excellence Capital
John P. Hornbostel
Counsel at Medical Excellence Capital
John Prufeta
Chief Executive Officer and Managing Partner at Medical Excellence Capital
Joni Mancini
Managing Partner at Medical Excellence Capital